Literature DB >> 31900902

Diet and Lifestyle in Prostate Cancer.

Kathryn M Wilson1, Lorelei A Mucci2.   

Abstract

A variety of diet and lifestyle factors have been studied with respect to prostate cancer risk in large, prospective cohort studies. In spite of this work, and in contrast to other common cancers, few modifiable risk factors have been firmly established as playing a role in prostate cancer. There are several possible explanations for the lack of well-established risk factors. First, prostate cancer has among the highest heritability of all common cancers; second, early life exposures may play an important role in risk, rather than mid- and later-life exposures assessed in most epidemiological studies. Finally, prostate-specific antigen (PSA) screening plays a critical role in prostate cancer detection and incidence rates, which has important implications for epidemiological studies.Among modifiable risk factors, smoking and obesity are consistently associated with higher risk specifically of advanced prostate cancer. There is also considerable evidence for a positive association between dairy intake and overall prostate cancer risk, and an inverse association between cooked tomato/lycopene intake and risk of advanced disease. Several other dietary factors consistently associated with risk in observational studies, including selenium and vitamin E, have been cast into doubt by results from clinical trials. Results for other well-studied dietary factors, including fat intake, red meat, fish, vitamin D, soy and phytoestrogens are mixed.In practical terms, men concerned with prostate cancer risk should be encouraged to stop smoking, be as physically active as possible, and achieve or maintain a healthy weight. These recommendations also have the advantage of having a positive impact on risk of type 2 diabetes, cardiovascular disease, and other chronic diseases. Reducing dairy intake while increasing consumption of fish and tomato products is also reasonable advice.

Entities:  

Mesh:

Year:  2019        PMID: 31900902     DOI: 10.1007/978-3-030-32656-2_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Association of plant-based diet index with prostate cancer risk.

Authors:  Stacy Loeb; Benjamin C Fu; Scott R Bauer; Claire H Pernar; June M Chan; Erin L Van Blarigan; Edward L Giovannucci; Stacey A Kenfield; Lorelei A Mucci
Journal:  Am J Clin Nutr       Date:  2022-03-04       Impact factor: 8.472

2.  Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.

Authors:  Rutu Hemani; Ishani Patel; Ninad Inamdar; Gisella Campanelli; Virginia Donovan; Avinash Kumar; Anait S Levenson
Journal:  Cancer Prev Res (Phila)       Date:  2021-10-21

3.  How inclusive are cell lines in preclinical engineered cancer models?

Authors:  Shreya Raghavan
Journal:  Dis Model Mech       Date:  2022-06-01       Impact factor: 5.732

Review 4.  Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.

Authors:  M S Petronek; J M Stolwijk; S D Murray; E J Steinbach; Y Zakharia; G R Buettner; D R Spitz; B G Allen
Journal:  Redox Biol       Date:  2021-01-16       Impact factor: 10.787

5.  An inverse association between plasma benzoxazinoid metabolites and PSA after rye intake in men with prostate cancer revealed with a new method.

Authors:  Elise Nordin; Stine K Steffensen; Bente B Laursen; Sven-Olof Andersson; Jan-Erik Johansson; Per Åman; Göran Hallmans; Michael Borre; Dan Stærk; Kati Hanhineva; Inge S Fomsgaard; Rikard Landberg
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

Review 6.  Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer.

Authors:  Ebuka-Olisaemeka Nwafor; Peng Lu; Ying Zhang; Rui Liu; Hui Peng; Bin Xing; Yiting Liu; Ziwei Li; Kuibin Zhang; Yukun Zhang; Zhidong Liu
Journal:  Transl Oncol       Date:  2021-11-30       Impact factor: 4.243

Review 7.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.